The obligate aerobic yeast Yarrowia lipolytica is introduced as a powerful new model for the structural and functional analysis of mitochondrial complex I. A brief introduction into the biology and the genetics of this nonconventional yeast is given and the relevant genetic tools that have been developed in recent years are summarized. The respiratory chain of Y. lipolytica contains complexes I -IV, one ''alternative'' NADH-dehydrogenase (NDH2) and a non-heme alternative oxidase (AOX). Because the NADH binding site of NDH2 faces the mitochondrial intermembrane space rather than the matrix, complex I is an essential enzyme in Y. lipolytica. Nevertheless, complex I deletion strains could be generated by attaching the targeting sequence of a matrix protein, thereby redirecting NDH2 to the matrix side. Deletion strains for several complex I subunits have been constructed that can be complemented by shuttle plasmids carrying the deleted gene. Attachment of a hexa-histidine tag to the NUGM (30 kDa) subunit allows fast and efficient purification of complex I from Y. lipolytica by affinity-chromatography. The purified complex has lost most of its NADH:ubiquinone oxidoreductase activity, but is almost fully reactivated by adding 400 -500 molecules of phosphatidylcholine per complex I. The established set of genetic tools has proven useful for the site-directed mutagenesis of individual subunits of Y. lipolytica complex I. Characterization of a number of mutations already allowed for the identification of several functionally important amino acids, demonstrating the usefulness of this approach. D
Introduction
With 43 subunits in mammals [1] [2] [3] , at least 35 subunits in fungi [4] and 13 to 14 subunits in procaryotes [5] , complex I (NADH:ubiquinone oxidoreductase) is the largest and most complicated enzyme of the respiratory chain. It contributes up to 40% of the proton gradient across the mitochondrial membrane [6] , is a prime source for oxygen radicals produced in the mitochondrial matrix [7] and is the target site for numerous mutations leading to mitochondrial dysfunction in humans [8 -11] . Yet, very little is known about its reaction mechanism, especially the interaction with ubiquinone and the coupling of electron transport and proton translocation [12, 13] . This is at least partly due to the lack of a convenient genetic approach to study the structure and function of this impressive enzyme complex. Here we present Yarrowia lipolytica, a nonconventional yeast for which a comprehensive set of well-developed genetic tools is available, as a powerful new model system for the structural and functional analysis of complex I.
What is Y. lipolytica?
Y. lipolytica, a dimorphic, heterothallic, ascomycetous yeast, is an obligate aerobe with a unique capability to utilize aliphatic carbon sources, including fatty acids and alkanes. This is in stark contrast to Saccharomyces cerevisiae, which prefers ethanolic fermentation, rather than respiration as mode of glucose utilization, even in the presence of oxygen [14] . In keeping with its saprophytic lifestyle, Y. lipolytica is proficient in secreting extracellular lipases [15] , acid [16] and alkaline [17] proteases and RNAse [18, 19] .
A small but very active and interactive community has been working on this nonconventional yeast, both on applied and basic research oriented topics. Reviews on Y. lipolytica as an experimental system can be found in Refs. [20, 21] .
Interest in Y. lipolytica has received a major boost by its usefulness for biotechnological applications. Apart from a certain role in traditional food technology, like the processing of cheese and other diary products [22, 23] , this yeast has been exploited for the production of single-cell protein for animal feeds, for the production of organic compounds like citric acid [24] and a-ketoglutaric acid [25] and for bioconversions of aliphatic compounds, e.g. the production of g-decalactone, a peachy aroma compound resulting from the peroxisomal beta-oxidation of ricinoleic acid [26] .
Another emerging issue is the secretion of recombinant proteins. Vectors have been constructed that allow for the Nterminal fusion of the secretion signal of the extracellular alkaline protease (XPR2) to heterologous proteins. For highlevel expression, a strong hybrid promoter consisting of four copies of an upstream activator sequence (UAS1) from the XPR2 locus [27] , fused to the LEU2 minimal promoter, can be used. In a comparative study, Y. lipolytica outmatched other yeast species since it consistently showed good to excellent secretion of a number of model proteins [28] . Protein expression in this organism does not require induction with methanol, which makes Y. lipolytica a favourable expression system for proteins intended for use in food technology.
Some of the research efforts that have benefited from the unique physiological properties of Y. lipolytica may be highlighted briefly here: Peroxisome biogenesis can be induced by shifting from glucose to acetate or aliphatic carbon sources [29, 30] . Similarly, peroxisome degradation is triggered by shifting from acetate/oleate/ethylamine into glucose plus ammonium sulfate-containing media [31] . Among many others, the pex16-1 strain was isolated in a screen for the inability to utilize oleic acid as a sole carbon source [32] . The Arabidopsis thaliana shrunken seed 1(sse1) gene was able to restore growth on oleic acid to the Y. lipolytica pex16-1 mutant strain [33] , pointing at fundamental similarities between the roles of the two proteins in oil body and peroxisome biogenesis, respectively. The Y. lipolytica PEX16 gene was found to encode a yet unknown intraperoxisomal peripheral membrane protein. Using this gene as a probe, the human homologue was isolated from a liver cDNA library, which was then shown to underlie one form of Zellweger syndrome [34] .
Single-cell to hyphae transition has been associated with pathogenesis in Candida albicans [35] . Studies in the nonpathogenic model organism Y. lipolytica have revealed several genes that are essential for filament formation [36 -39] . These studies may help to identify novel targets for the development of antifungal drugs.
Y. lipolytica genetic tools
After the discovery of sexual reproduction in Candida lipolytica [40] , the species was first renamed Saccharomycopsis lipolytica and later Yarrowia lipolytica [41] . Most natural isolates of Y. lipolytica are in the haploid state and grow vegetatively [40] . Mating frequency and spore viability are low, even with laboratory strains that were made isogenic by inbreeding. Y. lipolytica is heterothallic and both mating type alleles, MatA [42] and MatB [Kurischko, personal communication], have been cloned. Silent cassettes or mating type switching, as in S. cerevisiae [43] , have never been observed.
A number of classical mutants (auxotrophies for amino acids and nucleotides, resistance to antibiotics and antimetabolites, colour and colony morphology mutants) were isolated following mutagenesis by UV-light or alkylating agents [44] . The use of resistance genes as dominant markers is problematic, since Y. lipolytica is naturally resistant against a variety of antibiotics like chloramphenicol and G418 [45] and the broad-range biozide BASTA (Kerscher, unpublished observation). However, the hygromycin B phosphotransferase (hph) gene from E. coli [46] has been used successfully as resistance marker [45, 47] .
Inbred strains have been developed in several laboratories. The E129 (MatA, lys11-23, ura3-302, leu2-270, xpr2-322) and E150 (MatB, his-1, ura3-302, leu2-270, xpr2-322) strains (the latter strain is also the standard used in the Y. lipolytica genome project) carry nonreverting alleles of ura3 and leu2 that have been generated by the pop-in-pop-out strategy [20, 21] .
Low-copy plasmids that are based on chromosomal ARS/CEN regions [48] have been developed, which are useful tools to study the effects of in-vitro mutagenized genes when expressed at a level comparable to the original chromosomal context. Several strong and regulated promoters are known, including the XPR2 [49] , ICL1 [50] , POX2 [51] and POT1 [52] promoters. Using the ICL1 (isocitrate lyase 1, a gene from the anaplerotic glyoxylate cycle) promoter an 8 -14-fold increase in target protein expression was observed when glucose-grown cells were transferred into ethanol-acetate-or alkane-containing medium [53] . High transgene copy numbers can be achieved by targeting chromosomal integration to the LTR of the retrotransposon Ylt1 [54] . A promoter-deficient URA3 marker gene has been constructed that allows for the screening of multiple integration events when included on the fragment bearing the transgene. A shuttle mutagenesis system, which is based on a derivative of the Escherichia coli transposon Tn3, has been developed and successfully applied to isolate mutants defective in filamentous growth and in alkane and fatty acid utilization [55, 56] .
Highly representative genomic libraries for use in the S. cerevisiae two-hybrid system have been generated and successfully used to demonstrate the interaction between the endoplasmic reticulum protein Sls1p and Kar2p, an ER luminal member of the HSP70 family [57] .
Y. lipolytica genomics
The Y. lipolytica genome is currently being sequenced in a collaborative effort, involving several research groups. Terminal-sequencing of randomly chosen genomic clones from a plasmid library under the framework of the Genolevures project at GENOSCOPE, Centre National de Sequenage, Evry, France, has yielded 4940 random sequence tags [58] .
Sequencing of the mitochondrial genome of Y. lipolytica ( Fig. 1 ) has been accomplished by contiging the sequences of mitochondrial DNA HindIII fragments with sequences from the Genolevures project and filling the remaining small gaps by direct sequencing of PCR products [59] . As expected, this project yielded the sequences of seven complex I subunits (ND1-6, ND4L), one complex III subunit (apocytochrome B), three complex IV subunits (I, II, III), three complex V subunits (6, 8, 9) and the large and small subunits of mitochondrial RNA. Interestingly, the set of mitochondrial tRNAs is incomplete. There is no tRNA able to read CGN codon; consequently, such codons are not found in exonic ORF, while they are still present in some of the intronic ORFs which therefore must be regarded as pseudogenes [59] .
The respiratory chain of Y. lipolytica
The respiratory chain of Y. lipolytica is more similar to its counterpart from mammals than to that from fermentative yeasts like S. cerevisiae. The side chain of ubiquinone from Y. lipolytica is composed of nine isoprenoid units (Q 9 ), rather than six units (Q 6 ) as in S. cerevisiae [60] . Again in contrast to S. cerevisiae, Y. lipolytica does possess complex I, which is composed of an estimated 35 or more subunits [61] . This proton-pumping NADH:ubiquinone oxidoreductase is essential for survival of wild-type Y. lipolytica, as deletions in complex I subunit genes can only be generated in diploid standard strains and maintained as recessive lethal alleles in the heterozygous state. This initially presented one of the major hurdles in establishing Y. lipolytica as a model system for complex I genetics, which has been overcome only recently (see below). On the other hand, the fact that complex I is essential makes Y. lipolytica susceptibile to complex I inhibitors like 2-decyl-4-quinazolinyl amine (DQA), thus making Y. lipolytica an attractive model to screen for inhibitor resistant mutations.
The respiratory chain of Y. lipolytica also contains two enzymes that are not present in mammals, namely the ''alternative'' enzymes NDH2 and AOX. NDH2 is a single subunit NADH:ubiquinone oxidoreductase that carries out the same redox reaction as complex I but does not contribute to the transmembrane proton gradient [62] . Unlike complex I, it does not accept deaminoNADH [63] as an electron donor. We could demonstrate that in contrast to S. cerevisiae and N. crassa, there is only one type of alternative NADHdehydrogenase present in Y. lipolytica with its NADH reactive site oriented towards the external face of the mitochondrial inner membrane [64] . Since most mitochondrial redox shuttles described for mammalian [65] and fungal cells [66, 67] that are designed to transport NADH made in the cytosol into the mitochondrial matrix are not readily reversible, shuttling of reduction equivalents from the mitochondrial matrix to the cytosol is problematic. External orientation, therefore, means that NDH2 cannot stand in for complex I to oxidize NADH generated in the mitochondrial matrix. This explains why complex I is an essential enzyme in Y. lipolytica. NDH2 of Y. lipolytica thus functions to transfer electrons from cytoplasmic NADH to the respiratory ubiquinone pool. Deletion of NDH2, however, did not appreciably affect viability or growth rate on several complete and minimal media, showing that there must be redundant pathways that fulfil this role [64] .
AOX, the cyanide-resistant alternative terminal oxidase, is also a single subunit enzyme that carries out electron transfer from ubiquinol directly to molecular oxygen, bypassing complexes III and IV [68] . This energy dissipating and wasteful reaction must be tightly controlled; consequently, AOX activity has only been detected in Y. lipolytica when complexes III or IV are poisoned. Interestingly, AOX seems to be produced in an inactive form when cells enter the stationary phase and becomes activated under stress conditions that dramatically increase the content of AMP [69] .
We have recently cloned AOX from Y. lipolytica (Gen-Bank accession number AJ428416). The protein sequence conforms to the requirements of the revised structural model [70] for the active site of alternative oxidase. According to this model, the ligands for the hypothetical active site diiron centre are located in a four helix bundle, with helices 2 and 3 in an antiparallel orientation to helices 1 and 4. We conclude that in Y. lipolytica AOX the ligands to the di-iron centre are E157 (helix 1), E196 and H199 (helix 2), E248 (helix 3) and E301 and H304 (helix 4). E196 and E301 are the bridging carboxylates, while E157 and E248 are the terminal ligands. While the two EXXH (X = any amino acid) motifs in helix 2 and 4 are always present, a third EXXH motif is found in helix 3 of most alternative oxidases. The latter motif was proposed to provide two ligands for the di-iron centre in an earlier model [71] , but it has since become apparent that the histidine of this motif is not strictly conserved. In Y. lipolytica, like in Trypanosoma brucei [72] , its position is occupied by isoleucine.
A comparison of the inventory of alternative enzymes present in Y. lipolytica and S. cerevisiae raises some interesting issues. Three NDH2 homologues are present in S. cerevisiae. Two of them have an external orientation [73] , while one is an internal enzyme [74 -76] and may be regarded as the metabolic substitute for complex I. AOX is not present in S. cerevisiae and other fermentative yeasts, indicating that whatever function the enzyme may have in limiting respiratory chain ATP production or in preventing the generation of oxygen radicals, it seems to become obsolete in the absence of complex I.
NDH2i: an internal version of NDH2
S. cerevisiae does not need complex I because it contains an internal alternative NADH:ubiquinone oxidoreductase. In Aspergillus niger [77] and in N. crassa [4] complex I deletions are viable, which has been explained by postulating that these organisms contain an internal NADH-dehydrogenase as well. Therefore, we reasoned that constructing transgenic strains of Y. lipolytica that possess an internal version of the alternative enzyme might allow for survival of Y. lipolytica cells lacking functional complex I. A first attempt using the SCNDI1 gene was unsuccessful since the S. cerevisiae enzyme obviously was not imported into Y. lipolytica mitochondria [47] . We then fused the mitochondrial targeting sequence of the complex I NUAM subunit to a truncated version of Y. lipolytica NDH2. The NDH2i transgene could grow in the presence of up to 10 AM of the complex I inhibitor DQA and the isolation of haploid strains carrying deletions in central subunits of complex I became possible [47] . With respect to NDH2 itself, these findings strongly suggest that alternative NADH:ubiquinone oxidoreductases do not require specific proteins for membrane attachment, cofactor insertion and enzymatic function in Y. lipolytica. It may be speculated that the presence of one, externally oriented alternative enzyme, as seen in Y. lipolytica, represents the evolutionary ancestral situation and that internal NDH2 was recruited by the acquisition of a mitochondrial targeting sequence [62] .
Complex I from Y. lipolytica
Complex I from Y. lipolytica is very stable and allows for straightforward purification. Two different purification procedures have been developed in our laboratory. One of the protocols employs ion exchange and size exclusion chromatography [61] while the other method is based on His-tag affinity chromatography [78] .
The His-tag purification protocol offers efficient large scale isolation of highly pure complex I. A hexa-histidine sequence was attached to the C terminus of the NUGM (30 kDa) subunit. It was found that the insertion of a hexaalanine linker sequence between His-tag and the native C terminus resulted in slightly stronger binding to the affinitycolumn.
Cells grown in a 10-l fermenter are disrupted by a flowthrough cell disintegrator (Euler, Frankfurt, Germany) ensuring efficient and gentle processing of large quantities of cells. Mitochondrial membranes are solubilized with laurylmaltoside and applied to a Ni 2 + chelating resin. Finally, a size exclusion step removes residual impurities and rechromatography for analytical purposes on the same column gives rise to a single and symmetric peak. Up to 50 mg of pure and homogenous protein has been obtained in 1 day by this method.
The examination of complex I from Y. lipolytica by electron paramagnetic resonance (EPR) spectroscopy revealed quite similar characteristics as had been reported for bovine heart complex I [79] or N. crassa complex I [80] . In the NADH reduced state of purified complex I from Y. lipolytica five iron sulfur clusters are detectable by EPR spectroscopy. According to their increasing spin relaxation rates these clusters were designated N1 ( g z,y,x = 2.018, 1.945, 1.933), N2 ( g z,y,x = 2.051, 1.926, 1.918), N3 ( g z,y,x = 2.031, 1.930, 1.861), N4 ( g z,y,x = 2.104, 1.931, 1.892) and N5 ( g z,y,x = 2.062, 1.93, f 1.89) [81, 82] . N1 is a [2Fe -2S] cluster showing an EPR spectrum at temperatures even above 30 K. Until now, there is no evidence for the existence of other binuclear clusters like N1a and N1b in the bovine enzyme [83] or N1a, N1b and N1c in the enzyme from E. coli [84] . The other clusters in complex I from Y. lipolytica are of tetranuclear [4Fe -4S] type and can be detected at temperatures below 20 K. The EPR spectrum recorded at 12 K shows contributions of four iron sulfur clusters (Fig. 2) . Quantitation based on simulations of the individual spectra suggests a 1:1:1:1 stoichiometry for these four clusters. Due to its very high spin relaxation rate, cluster N5 is only detectable at temperatures below 10 K and high microwave power. A similar cluster was only detected in complex I from bovine heart [79] and Rhodo-bacter sphaeroides [84] . The spin concentration for N5 is very low as compared to the other four clusters and it is still a matter of debate whether this EPR signal originates from a real component of complex I.
As judged by the complex I specific electron transfer rate from NADH to the artificial electron acceptor hexaammineruthenium(III)-chloride (HAR), the overall yield of the preparation is 30 -40% of the total activity in membranes and the specific activity is increased by a factor of 70 during purification [78] . However, the specific NADH:n-decylubiquinone (DBQ) oxidoreductase activity did not increase concomitantly and for the purified enzyme is even lower than in mitochondrial membranes. The NADH:HAR activity of complex I was assigned to a three-subunit subcomplex (flavo-iron -sulfur protein) of the peripheral arm of complex I [85] , while the NADH:DBQ activity employs the entire electron pathway through the whole complex. Therefore, the dramatic loss in ubiquinone reductase activity could have been due to the removal of a functionally essential component of the complex during the purification procedure. Since the purified enzyme was shown to contain bound FMN and no changes in the EPR spectra of iron sulfur clusters were detectable [61, 78] , we analyzed whether a tightly bound ubiquinone [13] or specific phospholipds were required for the reaction with hydrophobic ubiquinone: The affinitypurified complex I from Y. lipolytica was found to contain 0.2 -0.4 mol/mol Q 9 and 30 -60 mol/mol phospholipid (Dröse and Brandt, submitted for publication) and has lost virtually all of its NADH:DBQ oxidoreductase activity. This preparation could be reactivated to near membrane levels also regaining full inhibitor sensitivity by reconstitution into asolectin (crude chloroform/methanol extract of soy bean lipids) proteoliposomes [78] . In a more detailed study, we found that the NADH:DBQ activity could typically be stimulated from 0.1 -0.2 up to 5 AmolÁmin À 1 Ámg À 1 by the addition of 400 -500 mol solubilized phospholipids per mole of complex I (Drö se and Brandt, submitted for publication). This activity corresponds well with the turnover number estimated for mitochondrial membranes (Table  1) . Remarkably, almost the same reactivation could be achieved if highly pure phosphatidylcholine from egg yolk or other sources was used. With phosphatidylethanolamine and cardiolipin, lower but still remarkable ubiquinone reduction rates were obtained (Table 1 ). We conclude that affinity purified complex I from Y. lipolytica can be fully reactivated by adding a layer of neutral phospholipid and that the loss of activity is not due to extraction of a tightly bound ubiquinone.
Mutagenesis of complex I
Y. lipolytica strains suitable for the genetic analysis of complex I were generated in the following way: The nuclear genes NUAM, NUBM, NUCM, NUGM, NUHM, NUIM and NUKM, encoding the seven central, highly conserved subunits of complex I (corresponding to the 75-, 51-, 49-, 30-, 24-kDa, TYKY and PSST subunits from bovine heart complex I, respectively), were all cloned by the same strategy: Degenerate primers were designed that correspond to amino acid stretches strictly conserved between N. crassa, Bos taurus and Paracoccus denitrificans. The resulting PCR products were used to screen an ordered genomic library of Y. lipolytica prepared in plasmid pBluescriptSK À . Sequence analysis demonstrated that all these genes are intronless in Y. lipolytica. Then, genetically marked deletions of these seven genes were generated in diploid cells by homologous recombination with a nuclear DNA fragment in which the ORF had been replaced by one of the marker genes URA3 or LEU2. Introduction of the NDH2i gene on a low-copy plasmid and sporulation yielded haploid complex I deletion strains. To achieve integration into the nuclear genome, the NDH2i gene was transformed as a 4.3-kb SalI fragment into the haploid ndh2D strain GB5.2, which was chosen since it showed low background growth on DQA plates. Random integration events which lead to high NDH2i expression levels, presumably due to ''trapping'' of nearby enhancers, were selected by their resistance to 2 and 5 AM DQA.
The chromosomal copy of the NUGM gene encoding the 30-kDa subunit was replaced by the NUGM-HT2 allele in which the ORF is extended by six alanine and six histidine codons by the pop-in-pop-out strategy (Fig. 3 ). This strategy, which is also generally useful for introducing mutations into genes in their original chromosomal location, consists of two steps: In the pop-in step, a single homologous recombination event with the target gene (here: NUGM) leads to the generation of a tandem repeat, with a marker gene (here: URA3) inserted in between and with one of the gene copies carrying the desired mutation. In the pop-out step, recombination between the two repeat units leads to loss of the marker gene. Negative selection (for loss of the URA3 marker) is possible by screening for resistance to 5Vfluoroacetic acid. The remaining copy of the target gene may be either wild-type or mutated, depending on where the recombination breakpoint is located. In the case of the NUKM gene, both the wild-type and the HT2 allele could be discerned by PCR using a primer pair that flanks the Cterminal end of the NUKM ORF.
Standard mating and sporulation techniques were then used to generate haploid strains that carry NDH2i, NUKM-HT2, and a genetically marked deletion in one of the six central, nuclear coded genes NUAM, NUBM, NUCM, NUHM, NUIM and NUKM. Since aneuploid strains may occur after sporulation in Y. lipolytica, all these strains were checked for the absence of the corresponding wild-type gene copy by Southern blot analysis.
Complementation of all complex I deletion strains was possible by introducing a wild-type copy of the deleted gene on a low-copy replicative plasmid and could be demonstrated by deaminoNADH:ubiquinone activity of mitochondrial membranes and or by blue-native gel electrophoresis [86] . Site-directed mutants could then be generated on low-copy plasmids, but may also be integrated into the genome by random integration or by homologous recombination with the wild-type allele. As long as a mutation does not result in assembly defects or instabilities, no reduction in the expression levels of complex I has been observed so far.
Exploring the catalytic core of complex I from Y. lipolytica
Several subunits of complex I are homologous to subunits of water-soluble [NiFe] hydrogenases from Desulfovibrio species [87] , for which molecular structures are known [88, 89] , and membrane-bound [NiFe] hydrogenases from various sources [90] . Since this homology has been reviewed recently [91] , it is summarized only briefly here. The 49-kDa and the PSST subunits of complex I correspond to the large and small subunits of water-soluble [NiFe] hydrogenases. In membrane bound [NiFe] hydrogenases, the small subunit has suffered a deletion that removed two out of three [4Fe -4S] clusters. These were replaced by two [4Fe -4S] clusters located in a newly acquired ferredoxinlike subunit, corresponding to the TYKY subunit in complex I [92] .
In recent years, a wealth of experimental data have been collected that underscore the importance of these evolutionary conserved subunits for enzymatic catalysis in complex I.
Leigh syndrome (subacute necrotizing enzephalomyelopathy) may be caused by point mutations in the genes NDUFS7 [93] , encoding the PSST homologue and NDUFS8 [94] , encoding the TYKY homologue. By reconstruction of these point mutations at the corresponding positions in complex I from Y. lipolytica, it was found that the ''Leigh mutant'' forms of complex I shared common characteristics: V max was reduced by about 50%, subtle changes in the K m for N-decyl-ubiquinone and the I 50 for hydrophobic inhibitors were observed [95] . Hypertrophic cardiomyopathy and encephalomyopathy were found to be associated with mutations in the NDUFS2 gene, encoding the 49-kDa homologue [96] .
A photoreactive derivative of the complex I inhibitor pyridaben was found to specifically label the PSST subunit [97] and a ''classical'' inhibitor resistant mutation (V470M) was identified in the 49-kDa subunit of complex I from Rhodobacter capsulatus [98] . The fact that this valine can be lined up with one of the cysteine ligands for the [NiFe] active site of the water-soluble hydrogenase from Desulfovibrio species prompted us to investigate whether despite the lack of the [NiFe] cluster and its cysteine ligands in complex I and despite low overall sequence similarity, the active sites of both enzymes were located at corresponding positions.
Based on this hypothesis, a structural model for the active site of complex I was constructed by placing the side chains of residues that are strictly conserved within the 49-kDa subunit of complex I into the corresponding positions of the large subunit of the [NiFe] hydrogenase from Desulfovibrio fructosovorans [99] . When this model was tested by site-directed mutagenesis of these residues, basically two types of effect were found: Resistance to complex I inhibitors like rotenone and DQA was observed with mutations that cluster around the former [NiFe] site, while effects on the EPR signal of cluster N2 were observed with mutations that map closer to the interface with the PSST homologous subunit [100] . Similarly, we could demonstrate that mutations that replace acidic residues within the PSST homologue with the corresponding amide displayed effects on the EPR signal of cluster N2 [101] . The fact that the molecular phenotypes of the complex I mutants followed a spatial gradient pattern consistent with their positions in the D. fructosovorans [NiFe] hydrogenase led us to conclude that the overall structural fold is evolutionary conserved between these two enzymes. Our structural model implies that the ubiquinone binding site of complex I was at least in part derived from the active site of [NiFe] hydrogenases and that cluster N2, which has been proposed to be directly involved in proton pumping [12, 13] , is located in the PSST homologue and corresponds to the proximal [4Fe -4S] cluster of [NiFe] hydrogenases.
